🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2032

Annual patent cliff calendar for 2032 — US pharmaceutical patents by expiration date.

Patents
1,123

Quick answer

1,123 indexed pharmaceutical patents have expiration dates in 2032. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8133859

    SCGB3A2 as a growth factor and anti-apoptotic agent

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8133917

    Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8133904

    Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

    Jenrin Discovery, LLC · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8133902

    Ammosamides as anticancer agents

    The Regents of the University of California · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8133870

    Therapeutic furopyrimidines and thienopyrimidines

    BioCryst Pharmaceuticals, Inc. · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8133865

    von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage

    Nektar Therapeutics · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8133861

    Systemic purine administration: modulating axonal outgrowth of central nervous system neurons

    Alseres Pharmaceuticals, Inc. · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8133495

    Live attenuated antigenically marked classical swine fever virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8138351

    Treatment of duchenne muscular dystrophy

    Summit Corporation Plc · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8137960

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8138345

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance, Inc. · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8138312

    Compositions for regulation of tumor necrosis factor-alpha

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8138216

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8138383

    Membrane active heteropolymers

    Arrowhead Madison, Inc. · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8138147

    Conditioned cell culture medium compositions and methods of use

    SkinMedica, Inc. · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8138310

    Chimeric CD154 polypeptides

    The Regents of the University of California · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8138140

    Self-assembling peptide amphiphiles and related methods for growth factor delivery

    Northwestern University · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8137699

    Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8137672

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8137695

    Polyconjugates for in vivo delivery of polynucleotides

    Arrowhead Madison, Inc. · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8142809

    Compositions and methods to lower glycohemoglobin levels

    Regent of the Univ. of Minnesota · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8143258

    Benzothiazole compounds useful for Raf inhibition

    Takeda Pharmaceutical Company Limited · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8143277

    Method of using compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8143297

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8143226

    Tyrosine kinase receptor antagonists and methods of treatment for breast cancer

    The Regents of the University of California · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8143390

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8142787

    Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

    United States of America as represented by the Secretary of the Air Force · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8143218

    Treatment of skin, and wound repair, with thymosin beta 4

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8143412

    Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)

    The Board of Regents of the University of Texas System · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8143214

    Protein-polymer conjugates

    PHARMAESSENTIA CORPORATION · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8143445

    HDAC inhibitors

    Lixte Biotechnology, Inc. · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8143418

    Dimeric small molecule potentiators of apoptosis

    The Board of Regents of the University of Texas System · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8143378

    Polymer factor VIII moiety conjugates

    Nektar Therapeutics · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8143298

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8143308

    Synthesis of oligo/poly(catechins) and methods of use

    The United States of America as represented by the Secretary of the Army · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8143295

    Compounds having activity in correcting mutant-CFTR processing and uses thereof

    The Regents of the University of California · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8143279

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8143232

    Gene fusion targeted therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8143276

    4-thio substituted quinoline and naphthyridine compounds

    XTL BIOPHARMACEUTICALS LTD. · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8143252

    Tetrahalogenated compounds useful as inhibitors of angiogenesis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8143257

    Substituted phenols as active agents inhibiting VEGF production

    PTC THERAPEUTICS, INC. · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8147840

    Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8148571

    Compound, composition comprising the same, and process for production of polymerizable amide

    Kuraray Medical Inc. · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8148576

    Solid state forms of aliskiren compounds

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8148510

    Antifungal polypeptides

    The Regents of the University of California · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8148560

    Vaginal tablets comprising misoprostol and methods of making and using the same

    TEVA WOMEN'S HEALTH, INC. · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8148525

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8148344

    Compositions and methods for mediating RNAi in vivo

    Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2032?

1,123 published patents in our USPTO index have expiration dates falling in calendar year 2032.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.